EHRA Premium Access

Incidence of new-onset atrial fibrillation after cavotricuspid isthmus ablation for isolated typical atrial flutter: a systematic review and meta-analysis

Presentation

About the speaker

Doctor Andrew Griffin

Royal Adelaide Hospital, Adelaide (Australia)
0 follower

6 more presentations in this session

Incidence and location of residual gaps identified by a high-density grid-style catheter after PVI is confirmed by pacing the ablation lines

Speaker: Doctor S. Sundaram (Littleton, US)

Thumbnail

Catheter ablation outscores all other treatment modalities in reducing all-cause mortality and heart failure related morbidity in patients of persistent atrial fibrillation with systolic heart failure

Speaker: Doctor D. Khanra (Liverpool, GB)

Thumbnail

Efficacy and safety of a high power short duration ablation-index guided protocol for pulmonary vein isolation using a single catheter

Speaker: Doctor P. Badertscher (Basel, CH)

Thumbnail

Shorter interlesion distance is associated with a longer procedure time but not with poorer acute results of pulmonary vein isolation: results from a prospective ablation index registry

Speaker: Doctor N. Gasimova (Saint Petersburg, RU)

Thumbnail

Is the optimal blanking period duration after cryoballoon pulmonary vein isolation impacted by use of antiarrhythmic drugs?

Speaker: Doctor D. Musat (Ridgewood, US)

Thumbnail

Access the full session

Treatment of atrial fibrillation and stroke prevention

Speakers: Doctor A. Griffin, Doctor S. Sundaram, Doctor D. Khanra, Doctor P. Badertscher, Doctor N. Gasimova...
Thumbnail

About the event

Image

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Related content

EHRA Premium Access

Validation of a multipolar pulsed field ablation catheter for endpoint assessment in pulmonary vein isolation procedures

5 April 2022

ESC Premium Access

Management (diagnosis and treatment) of syncope without prodromes, normal heart and normal ECG.

28 August 2021

This platform is supported by

logo Novo Nordisk